This page shows the latest Ilaris news and features for those working in and with pharma, biotech and healthcare.
CV data sets up Novartis' Ilaris for blockbuster sales. Drug shown to reduce major adverse cardiovascular events. ... Novartis has posted surprise phase III data that could transform the fortunes of its anti-inflammatory drug Ilaris, making it an option
Novartis' Ilaris wins three new FDA approvals. Immunotherapeutic expands in rare Periodic Fever Syndrome conditions. ... Novartis' anti-inflammatory therapy Ilaris (canakinumab) has received new US approvals for its use in three rare Periodic Fever
Novartis wins childhood arthritis indication for Ilaris in EU. EC gives green light to drug for the treatment of systemic juvenile idiopathic arthritis. ... Novartis' inflammatory disease drug Ilaris (canakinumab) can be used more widely in the EU
Jimenez also said Novartis had a fertile quarter in terms of its pipeline, with four approvals including Ilaris (canakinumab) for systemic juvenile idiopathic arthritis, Simbrinza (brinzolamide/brimonidine tartrate) for glaucoma, Lucentis
Novartis gets FDA green light for new Ilaris indication. Immunotherapeutic wins US approval for severe form of childhood arthritis. ... The new SJIA indication will add further momentum to Ilaris, which grew 56 per cent last year to reach $72m in sales.
Novartis' Ilaris cleared for gouty arthritis in EU. First biologic drug approved for condition in Europe. ... Ilaris was launched in the US and EU in 2009 as a treatment for an auto-inflammatory condition called cryopyrin-associated periodic syndrome
More from news
Approximately 4 fully matching, plus 6 partially matching documents found.
During his time at Novartis, de Vries led the discovery and early development of several drugs including Elidel (pimecrolimus) for eczema, Ilaris (canakunimab) for cryopyrin-associated periodic syndromes, Gilenya (fingolimod) for
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...